30 ACTUAT mometasone furoate 0.22 MG/ACTUAT Dry Powder Inhaler [Asmanex]
RxNorm concept 746813, branded drug (sbd). Prescribable name: Asmanex Twisthaler 220 MCG/INHAL Dry Powder Inhaler, 30 ACTUAT.
- RxCUI
- 746813
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/746813 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Asmanex 0.22 MG/ACTUAT Dry Powder Inhaler, 30 ACTUAT; Asmanex 220 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT
Related concepts
- mometasone furoate 0.22 MG/ACTUAT (SCDC, consists of)
- mometasone furoate 0.22 MG/ACTUAT [Asmanex] (SBDC, consists of)
- Dry Powder Inhaler (DF, has dose form)
- Asmanex (BN, has ingredient)
- 30 ACTUAT mometasone furoate 0.22 MG/ACTUAT Dry Powder Inhaler (SCD, tradename of)
Linked data
NDCs
- 00085134107
- 78206011404
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 746813 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/746813 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 746813. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.